Work

Antitumor activity and safety of pembrolizumab in patients (pts) with advanced squamous cell carcinoma of the head and neck (SCCHN): Preliminary results from KEYNOTE-012 expansion cohort.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.lba6008

Authors: Tanguy Y. Seiwert, Robert I. Haddad, Shilpa Gupta, Ranee Mehra, Makoto Tahara, Raanan Berger, Se-Hoon Lee, Barbara Burtness, Dung T. Le, Karl Heath, Amy Blum, Marisa Dolled-Filhart, Kenneth Emancipator, Kumudu Pathiraja, Jonathan D. Cheng, Laura Q. Chow

Institutions: University of Chicago, Dana-Farber Cancer Institute, Moffitt Cancer Center, Fox Chase Cancer Center, National Cancer Center Hospital East, Sheba Medical Center, Seoul National University Hospital, Yale Cancer Center, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Merck & Co., Inc., Rahway, NJ, USA (United States), University of Washington

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4243824768

Cites:

Cited by: 21

Related to: 10